Patent details
EP3291812 Title: INJECTABLE DEPOT FORMULATIONS
Basic Information
- Publication number:
- EP3291812
- PCT Application Number:
- US2016030912
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP167900661
- PCT Publication Number:
- WO2016179357
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- INJECTABLE DEPOT FORMULATIONS
- French Title of Invention:
- FORMULATIONS DE DÉPÔT INJECTABLES
- German Title of Invention:
- INJIZIERBARE DEPOTFORMULIERUNGEN
- SPC Number:
Dates
- Filing date:
- 05/05/2016
- Grant date:
- 01/09/2021
- EP Publication Date:
- 14/03/2018
- PCT Publication Date:
- 10/11/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/09/2021
- EP B1 Publication Date:
- 01/09/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 05/05/2022
- Expiration date:
- 05/05/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 25/08/2021
- Name:
- EyePoint Pharmaceuticals US, Inc.
- Address:
- 400 Pleasant Street, Watertown, MA 02472, United States (US)
Inventor
- Name:
- ASHTON, Paul
- Address:
- United States (US)
Priority
- Priority Number:
- 201562157257 P
- Priority Date:
- 05/05/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/44; A61P 27/02; A61K 47/10; A61K 9/08;
Publication
European Patent Bulletin
- Issue number:
- 202135
- Publication date:
- 01/09/2021
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|